diabetes insulin
Biotech

Sana shares 14-month data for ‘functional cure’ diabetes program

Sana is evaluating a donor-derived primary islet cell therapy designed to serve as a Type 1 diabetes treatment that doesn’t require immunosuppression.
Gabrielle Masson Mar 13, 2026 10:55am
Three stacked cups with coffee spilling out of top one

Inovio trims team as trouble brews at FDA for rare disease drug

Mar 13, 2026 10:03am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
Golfer devastated after just barely missing a putt

Immutep's ph. 3 failure surprises analysts, sinks stock

Mar 13, 2026 9:53am
Parachute over a desert

BioNTech founders to pioneer new company—Chutes & Ladders

Mar 13, 2026 8:30am
Red light traffic

Insulet recalls certain Omnipod 5 pumps over insulin leaks

Mar 13, 2026 1:12pm
More News

China approves 1st brain-computer implant for paralyzed patients

Mar 13, 2026 11:27am

Fierce Biotech Layoff Tracker 2026: Vistagen, Evotec & more

Mar 13, 2026 10:30am

Biotech unit Pfizer Ignite flames out

Mar 12, 2026 3:58pm

Vistagen lays off 20% of staff to focus on anxiety candidate

Mar 12, 2026 1:16pm